넳 넲

ONCOLOGY

ONCOLOGY

Product Name

CAS No.

Specification

Regulatory Status

Granisetron Base
IHS
USDMF No. 22089, USFDA Approved
Granisetron HCl
USDMF No. 19365, USFDA Approved CEP: R1-CEP 2009-341-Rev03, UK GMP Stability Studies In Zone IVB.
BP/EP/USP
107007-99-8
107007-99-8
Luliconazole
187164-19-8
IHS
/
Miglitol
72432-03-2
IHS
T.P.
Neostigmine methylsulfate
‭51-60-5‬
EP/USP/JP
/
Pamidronate Disodium
57248-88-1
BP/EP/USP
Technical package
Pregabalin
/
IHS
148553-50-8
Pimecrolimus
137071-32-0
IHS
/
Ivabradine
155974-00-8
IHS
/
Lorcaserin
616202-92-7
IHS
/
Nebivolol HCl
169293-50-9
IHS
/
Glimepiride
93479-97-1
EP/USP/BP
USDMF No. 22561 USFDA Approved CEP: R0-CEP 2009-079-Rev01, UK GMP Written Confirmation
Levetiracetam
102767-28-2
EP/USP
DMF
끸
Verification Code
Submit
HAORUI ENTERPRISES LIMITED (SHENZHEN HAORUI PHARMATECH CO., LTD.)

Address: RM503, Wanhai Building B, Nanhai Avenue Nanshan District,Shenzhen 518067 P.R. China.

 

Tel: (86) 755-82960263 (For All) 

 

Web: www.haorui.com

 

Email: info@haorui.com